General Information of the Compound
| Compound ID |
CP0437003
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(3-(2-Chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-yl)-N-(5-(piperidin-1-yl)-1,3,4-thiadiazol-2-yl)propanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H18ClFN6O2S
|
||||||||||||||||||
| Molecular Weight |
436.9
|
||||||||||||||||||
| Canonical SMILES |
Fc1ccc(-c2noc(CCC(=O)Nc3nnc(s3)N3CCCCC3)n2)c(Cl)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H18ClFN6O2S/c19-13-10-11(20)4-5-12(13)16-22-15(28-25-16)7-6-14(27)21-17-23-24-18(29-17)26-8-2-1-3-9-26/h4-5,10H,1-3,6-9H2,(H,21,23,27)
Show/Hide
|
||||||||||||||||||
| InChIKey |
LZJGVMWZHJLDFT-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01298, Cannabinoid receptor 1
Protein ID: PT02190, Cannabinoid receptor 1
Protein ID: PT00834, Cannabinoid receptor 2
Protein ID: PT02333, Cannabinoid receptor 2